HeraMED Limited (ASX:HMD)
Australia · Delayed Price · Currency is AUD 0.0360
0.00 (0.00%)
Feb 26, 2026, 12:48 PM AEST
HeraMED Market Cap
HeraMED has a market cap or net worth of 40.09 million as of February 25, 2026. Its market cap has increased by 128.94% in one year.
Market Cap
40.09M
Enterprise Value
39.14M
Revenue
322.93K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since December 12, 2018, HeraMED's market cap has increased from 15.76M to 40.09M, an increase of 154.47%. That is a compound annual growth rate of 13.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 40.09M | 4.06% |
| Dec 31, 2025 | 38.53M | 120.00% |
| Dec 31, 2024 | 17.51M | 127.12% |
| Dec 29, 2023 | 7.71M | -74.58% |
| Dec 30, 2022 | 30.33M | -32.86% |
| Dec 31, 2021 | 45.18M | 173.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 84.85M |
| Compumedics | 67.92M |
| Micro-X | 50.83M |
| CleanSpace Holdings | 46.14M |
| Nova Eye Medical | 45.57M |
| CurveBeam AI | 32.96M |
| ImpediMed | 32.62M |
| Atomo Diagnostics | 30.79M |